Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Zeitz

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Inflammatory Intestinal Diseases|June 14, 2021
Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal MucosaSimona Simmen, Max Maane, Sarah Rogler, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68)Cheryl de Vallière, Jesus Cosin-Roger, Simona Simmen, et al.
BMJ Open|January 7, 2017
Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD StudyStephan Vavricka, Pedro A Ruiz, Sylvie Scharl, et al.
Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF TreatmentThomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
The New England Journal of Medicine|June 30, 2021
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac DiseaseDetlef Schuppan, Markku Mäki, Knut E A Lundin, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Inflammatory Intestinal Diseases|June 14, 2021
Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal MucosaSimona Simmen, Max Maane, Sarah Rogler, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2017
Hypoxia Positively Regulates the Expression of pH-Sensing G-Protein-Coupled Receptor OGR1 (GPR68)Cheryl de Vallière, Jesus Cosin-Roger, Simona Simmen, et al.
BMJ Open|January 7, 2017
Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD StudyStephan Vavricka, Pedro A Ruiz, Sylvie Scharl, et al.
Inflammatory Bowel Diseases|April 29, 2017
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort StudyStephan R Vavricka, Martin Gubler, Claudine Gantenbein, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 2, 2016
Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF TreatmentThomas Greuter, Fabio Bertoldo, Roman Rechner, et al.
The New England Journal of Medicine|June 30, 2021
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac DiseaseDetlef Schuppan, Markku Mäki, Knut E A Lundin, et al.
Pageof 6